Abilify

In the US, Abilify (aripiprazole systemic) is a member of the drug class atypical antipsychotics and is used to treat Agitated State, Autism, Bipolar Disorder, Depression, Major Depressive Disorder, Schizoaffective Disorder and Schizophrenia.

US matches:

UK matches:

Ingredient matches for Abilify

Aripiprazole

Aripiprazole is reported as an ingredient of Abilify in the following countries:

  • Australia
  • Austria
  • Bahrain
  • Belgium
  • Canada
  • Chile
  • China
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Malaysia
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • Tunisia
  • Turkey
  • United Kingdom
  • United States
  • Venezuela

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)